SPX3,695.13+40.09 1.10%
DIA295.16+2.44 0.83%
IXIC10,966.02+163.10 1.51%

JP Morgan Maintains Overweight on Immunocore Hldgs, Raises Price Target to $67

JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $60 to $67.

Benzinga · 09/14/2022 08:47
JP Morgan analyst Jessica Fye maintains Immunocore Hldgs (NASDAQ:IMCR) with a Overweight and raises the price target from $60 to $67.